Skip to main content

Table 2 Prevalence of factor V Leiden mutation and its association with SCD in Palestinian patients

From: Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease

Patient (n) FV Leiden Crude Adjusted
G/G G/A A/A OR (95% CI) P value OR (95% CI) P value
SS (59) 48 11 0 9.31(2.1–61.9) 0.027 5.6 (1.91–39.4) 0.039
AS (25) 23 1 1 8.4 (1.12–64.7) 0.038 3.97 (0.51–28.6) 0.17
S/βThal (33) 26 4 3 7.2 (0.63–75.4) 0.19 3.59 (0.35–41.6) 0.26
Controls 98 18 2 1 1